2025-11-20

#reports #UTI

[Universal Technical Institute](https://eninvs.com/all.php?name=UTI) (Education and Training Services) reported for 2025 q3
(2025-11-19, After Market Close):

- Revenue -40.2% YoY (vs +15.3% in previous quarter and historical rate +31.2%)
- EBITDA -31.3% YoY (vs +22.2% in previous quarter and historical rate +59.2%)
- EBITDA margin 14.9% increased compared to 12.9% same period last year
- Net Debt decreased by $39 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 4.7% of market cap
- EV/EBITDA multiple is 14.5x compared to historical level (75th percentile) of 14.5x
- EV/Sales multiple is 2.1x

The company showed EPS +$0.34 per share

------------------------------------------------

2025-11-20

#reports #GLBE

[Global-e Online Ltd.](https://eninvs.com/all.php?name=GLBE) (Internet Retail) reported for 2025 q3
(2025-11-19, Before Market Open):

- Revenue +25.6% YoY (vs +28.0% in previous quarter and historical rate +34.0%)
- EBITDA margin 8.1% increased compared to -11.4% same period last year
- Net Debt decreased by $37 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.5% of market cap
- EV/Sales multiple is 5.6x

The company showed EPS +$0.07 per share. At the opening of the session the share price went down -0.6% vs S&P500 -0.1%

------------------------------------------------

2025-11-20

#reports #PANW
@ cybersecurity

[Palo Alto Networks](https://eninvs.com/all.php?name=PANW) (Cybersecurity company) reported for 2025 q3
(2025-11-19, After Market Close):

- Revenue +15.7% YoY (vs +15.8% in previous quarter and historical rate +18.1%)
- EBITDA +6.3% YoY (vs +97.0% in previous quarter and historical rate +95.8%)
- EBITDA margin 15.7% decreased compared to 17.1% same period last year
- Net Debt decreased by $1.3 bln since the start of the year (1.0% of market cap)
- FCF (LTM) +$0.2 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 82.5x compared to historical level (75th percentile) of 126.9x
- EV/Sales multiple is 13.3x

The company showed EPS +$0.47 per share

------------------------------------------------

2025-11-19

#reports #VREX

[Varex Imaging](https://eninvs.com/all.php?name=VREX) (Components for X-ray detectors manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194325)
(2025-11-18, After Market Close):

- Revenue +11.2% YoY (vs -2.9% in previous quarter and historical rate -0.3%)
- EBITDA +40.9% YoY (vs -473.7% in previous quarter and historical rate -16.1%)
- EBITDA margin 13.5% increased compared to 10.7% same period last year
- Net Debt increased by $3 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 6.7% of market cap
- EV/EBITDA multiple is 104.4x compared to historical level (75th percentile) of 10.7x
- EV/Sales multiple is 0.9x

The company showed EPS +$0.29 per share

------------------------------------------------

2025-11-19

#reports #ESLT

[Elbit Systems](https://eninvs.com/all.php?name=ESLT) (Aerospace and Defense) reported for 2025 q3
(2025-11-18, Before Market Open):

- Revenue +11.9% YoY (vs +21.3% in previous quarter and historical rate +12.2%)
- EBITDA +30.3% YoY (vs +29.7% in previous quarter and historical rate +17.8%)
- EBITDA margin 11.2% increased compared to 9.6% same period last year
- Net Debt decreased by $200 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.4 bln (positive), 1.6% of market cap
- EV/EBITDA multiple is 29.5x compared to historical level (75th percentile) of 26.1x
- EV/Sales multiple is 3x

At the opening of the session the share price went up +3.9% vs S&P500 -0.4%

------------------------------------------------

2025-11-19

#reports #BRBR

[BellRing Brands](https://eninvs.com/all.php?name=BRBR) (Packaged Foods) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=BRBR&q=2025 q3&id=902611)
(2025-11-18, Before Market Open):

- Revenue +16.5% YoY (vs +6.4% in previous quarter and historical rate +19.3%)
- EBITDA -9% YoY (vs -56.8% in previous quarter and historical rate +30.0%)
- EBITDA margin 15.6% decreased compared to 20.0% same period last year
- Net Debt increased by $48 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0.2 bln (negative), 5.7% of market cap
- EV/EBITDA multiple is 13.4x compared to historical level (75th percentile) of 28.6x
- EV/Sales multiple is 2x

The company showed EPS +$0.48 per share. At the opening of the session the share price went down -4.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-18

#reports #ZYXI

[Zynex](https://eninvs.com/all.php?name=ZYXI) (Medical equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194320)
(2025-11-17, After Market Close):

- Revenue -74% YoY (vs -56.0% in previous quarter and historical rate -4.8%)
- EBITDA -960% YoY (vs -400.0% in previous quarter and historical rate -66.8%)
- EBITDA margin -330.8% decreased compared to 10.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (17.5% of market cap)
- FCF (LTM) -$0 bln (negative), 122.8% of market cap
- EV/Sales multiple is 0.7x

The company showed EPS -$1.42 per share

------------------------------------------------

2025-11-18

#reports #ENTA

[Enanta Pharmaceuticals](https://eninvs.com/all.php?name=ENTA) (Small molecular drugs manufacturer) reported for 2025 q3
(2025-11-17, After Market Close):

- Revenue -54.5% YoY (vs 0.0% in previous quarter and historical rate -4.9%)
- EBITDA margin -353.3% decreased compared to -193.9% same period last year
- Net Debt increased by $15 mln over the past reporting period (5.5% of market cap)
- FCF (LTM) -$0 bln (negative), 16.8% of market cap
- EV/Sales multiple is 2.2x

------------------------------------------------

2025-11-18

#reports #BRC

[Brady Corporation](https://eninvs.com/all.php?name=BRC) ( Identification products manufacturer ) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194318)
(2025-11-17, Before Market Open):

- Revenue +7.4% YoY (vs +15.7% in previous quarter and historical rate +16.6%)
- EBITDA +14.5% YoY (vs -5.4% in previous quarter and historical rate +17.1%)
- EBITDA margin 19.5% increased compared to 18.3% same period last year
- Net Debt increased by $10 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 11.7x compared to historical level (75th percentile) of 12.3x
- EV/Sales multiple is 2.2x

The company showed EPS +$1.11 per share. At the opening of the session the share price went up +2.8% vs S&P500 -0.3%

------------------------------------------------

2025-11-18

#reports #ARMK

[Aramark](https://eninvs.com/all.php?name=ARMK) (Catering, Facility and Human Resources Service provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=ARMK&q=2025 q3&id=902456)
(2025-11-17, Before Market Open):

- Revenue +14.3% YoY (vs +109.8% in previous quarter and historical rate +10.5%)
- EBITDA +75% YoY (vs +136.7% in previous quarter and historical rate +17.1%)
- EBITDA margin 11.5% increased compared to 7.5% same period last year
- Net Debt decreased by $1 bln since the start of the year (10.8% of market cap)
- FCF (LTM) -$1.2 bln (negative), 12.6% of market cap
- EV/EBITDA multiple is 7.9x compared to historical level (75th percentile) of 13.3x
- EV/Sales multiple is 0.6x

The company showed EPS +$0.33 per share. At the opening of the session the share price went down -5.8% vs S&P500 -0.3%

------------------------------------------------

2025-11-18

#reports #SOHU
@ china

[Sohu.com](https://eninvs.com/all.php?name=SOHU) (Online advertising service provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=SOHU&q=2025 q3&id=902467)
(2025-11-17, Before Market Open):

- Revenue +18.4% YoY (vs -26.7% in previous quarter and historical rate -8.3%)
- EBITDA +3.3% YoY (vs -2300.0% in previous quarter and historical rate -48.0%)
- EBITDA margin 469.4% decreased compared to 538.2% same period last year
- Net Debt decreased by $48 mln over the past reporting period (9.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 20.6% of market cap
- EV/Sales multiple is -0.6x

At the opening of the session the share price went up +4.7% vs S&P500 -0.3%

------------------------------------------------

2025-11-15

#reports #VNRX

[VolitionRx Limited](https://eninvs.com/all.php?name=VNRX) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194251)
(2025-11-13, After Market Close):

- Revenue +32% YoY (vs +2.8% in previous quarter and historical rate +103.8%)
- EBITDA margin -774.0% increased compared to -1175.6% same period last year
- Net Debt increased by $2 bln since the start of the year (6279.1% of market cap)
- FCF (LTM) -$8.9 bln (negative), 27728.9% of market cap
- EV/Sales multiple is 6.9x

At the opening of the session the share price went up +3.3% vs S&P500 -1.1%

------------------------------------------------

2025-11-15

#reports #FEMY

[Femasys Inc.](https://eninvs.com/all.php?name=FEMY) (Medical Instruments and Supplies) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194247)
(2025-11-06, After Market Close):

- Revenue +31.4% YoY (vs +85.1% in previous quarter and historical rate +54.0%)
- EBITDA margin -489.4% increased compared to -908.5% same period last year
- Net Debt decreased by $776 mln over the past reporting period (7318.9% of market cap)
- FCF (LTM) -$5 bln (negative), 47233.2% of market cap
- EV/Sales multiple is 1.2x

At the opening of the session the share price went down -0.2% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #OMI

[Owens & Minor](https://eninvs.com/all.php?name=OMI) (Logistic services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194224)
(2025-10-30, Before Market Open):

- Revenue -74.4% YoY (vs -74.5% in previous quarter and historical rate -9.6%)
- EBITDA +5.8% YoY (vs -76.2% in previous quarter and historical rate -20.5%)
- EBITDA margin 13.1% increased compared to 3.2% same period last year
- Net Debt increased by $144 mln over the past reporting period (81.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 62.0% of market cap
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -1.3% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #HSON

[Hudson Global](https://eninvs.com/all.php?name=HSON) (Staffing and Employment Services) reported for 2025 q3
(2025-08-08, Before Market Open):

- Revenue +29.7% YoY (vs 0.0% in previous quarter and historical rate +7.8%)
- EBITDA margin -4.2% decreased compared to 0.0% same period last year
- Net Debt increased by $24 mln over the past reporting period (90.7% of market cap)
- EV/Sales multiple is 0.2x

At the opening of the session the share price went up +3.1% vs S&P500 +0.2%

------------------------------------------------

2025-11-15

#reports #XTNT

[Xtant Medical](https://eninvs.com/all.php?name=XTNT) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194103)
(2025-11-03, Before Market Open):

- Revenue +17.9% YoY (vs +16.7% in previous quarter and historical rate +35.7%)
- EBITDA margin 12.1% increased compared to -10.7% same period last year
- Net Debt decreased by $27 mln over the past reporting period (29.1% of market cap)
- FCF (LTM) +$0 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 8.3x compared to historical level (75th percentile) of 33.3x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went up +0.1% vs S&P500 +0.6%

------------------------------------------------

2025-11-15

#reports #XBIO

[Xenetic Biosciences](https://eninvs.com/all.php?name=XBIO) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194100)
(2025-08-12, Before Market Open):

- Revenue +67.3% YoY (vs -18.7% in previous quarter and historical rate +49.9%)
- EBITDA margin -52.2% increased compared to -80.0% same period last year
- Net Debt increased by $658 mln over the past reporting period (16410.8% of market cap)
- FCF (LTM) -$2.1 bln (negative), 51377.2% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 4.7x
- EV/Sales multiple is -1.4x

------------------------------------------------

2025-11-15

#reports #VRME

[VerifyMe](https://eninvs.com/all.php?name=VRME) (Security and Protection Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194099)
(2025-11-05, Before Market Open):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +31.2%)
- Net Debt increased by $1 mln over the past reporting period (9.9% of market cap)
- FCF (LTM) +$0 bln (positive), 69.3% of market cap
- EV/EBITDA multiple is 0.6x compared to historical level (75th percentile) of 1.2x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +2.2% vs S&P500 -0.1%

------------------------------------------------

2025-11-15

#reports #UTMD

[Utah Medical Products](https://eninvs.com/all.php?name=UTMD) (Medical Instruments and Supplies) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194098)
(2025-05-15, Before Market Open):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +3.0%)
- EBITDA +66.7% YoY (vs 0.0% in previous quarter and historical rate -2.0%)
- EBITDA margin 50.0% increased compared to 30.0% same period last year
- Net Debt decreased by $2 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0.3 bln (positive), 151.8% of market cap
- EV/EBITDA multiple is 7.3x compared to historical level (75th percentile) of 12.1x
- EV/Sales multiple is 3x

At the opening of the session the share price went up +1.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #TPIC

[TPI Composites](https://eninvs.com/all.php?name=TPIC) (Industrial company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194096)
(2025-08-11, After Market Close):

- Revenue -38.6% YoY (vs -11.0% in previous quarter and historical rate -9.8%)
- EBITDA margin -33.3% decreased compared to -1.0% same period last year
- Net Debt decreased by $147 mln over the past reporting period (2432.0% of market cap)
- FCF (LTM) -$0 bln (negative), 165.4% of market cap
- EV/Sales multiple is 0.4x

At the opening of the session the share price went down -23.3% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #TELA

[TELA Bio](https://eninvs.com/all.php?name=TELA) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194092)
(2025-11-13, After Market Close):

- Revenue +10.5% YoY (vs +25.0% in previous quarter and historical rate +29.5%)
- EBITDA margin -33.3% increased compared to -47.4% same period last year
- Net Debt increased by $43 mln over the past reporting period (94.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 121.3% of market cap
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -5.4% vs S&P500 -1.1%

------------------------------------------------

2025-11-15

#reports #SMWB

[Similarweb Ltd.](https://eninvs.com/all.php?name=SMWB) (Internet Content and Information) reported for 2025 q3
(2025-11-11, After Market Close):

- Revenue +10.8% YoY (vs +16.4% in previous quarter and historical rate +14.0%)
- EBITDA margin -4.2% decreased compared to -3.1% same period last year
- Net Debt decreased by $5 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/Sales multiple is 1.9x

At the opening of the session the share price went down -15.1% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #SBH

[Sally Beauty](https://eninvs.com/all.php?name=SBH) (Professional cosmetics supplier ) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194083)
(2025-11-13, Before Market Open):

- Revenue +1.3% YoY (vs -1.0% in previous quarter and historical rate -1.0%)
- EBITDA -2.4% YoY (vs +3.0% in previous quarter and historical rate +6.1%)
- EBITDA margin 8.4% decreased compared to 8.8% same period last year
- Net Debt increased by $16 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0.7 bln (positive), 47.4% of market cap
- EV/EBITDA multiple is 7x compared to historical level (75th percentile) of 8x
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +6.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #RKDA

[Arcadia Biosciences](https://eninvs.com/all.php?name=RKDA) (Agricultural Inputs) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194081)
(2025-11-07, After Market Close):

- Revenue -50% YoY (vs 0.0% in previous quarter and historical rate -21.5%)
- EBITDA margin -100.0% has not changed compared to -100.0% same period last year
- Net Debt decreased by $2 mln over the past reporting period (38.8% of market cap)
- FCF (LTM) -$0 bln (negative), 77.7% of market cap
- EV/Sales multiple is -0.2x

At the opening of the session the share price went down -2.7% vs S&P500 +1.1%

------------------------------------------------

2025-11-15

#reports #REKR

[Rekor Systems](https://eninvs.com/all.php?name=REKR) (Software — Infrastructure) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194079)
(2025-11-13, After Market Close):

- Revenue +27.3% YoY (vs 0.0% in previous quarter and historical rate +45.7%)
- EBITDA margin -21.4% increased compared to -109.1% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0 bln (positive), 3.8% of market cap
- EV/Sales multiple is 2.5x

At the opening of the session the share price went down -4.4% vs S&P500 -1.1%

------------------------------------------------

2025-11-15

#reports #QUIK

[QuickLogic Corporation](https://eninvs.com/all.php?name=QUIK) (Semiconductors) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194076)
(2025-11-11, After Market Close):

- Revenue -50% YoY (vs 0.0% in previous quarter and historical rate +9.3%)
- EBITDA margin -150.0% decreased compared to -25.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) +$0 bln (positive), 6.2% of market cap
- EV/Sales multiple is 6x

At the opening of the session the share price went down -5.7% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #PXLW

[Pixelworks](https://eninvs.com/all.php?name=PXLW) (Semiconductors) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194073)
(2025-11-11, After Market Close):

- Revenue -10% YoY (vs -11.1% in previous quarter and historical rate -17.2%)
- EBITDA margin -55.6% increased compared to -80.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0 bln (negative), 2.4% of market cap
- EV/Sales multiple is 12.7x

At the opening of the session the share price went up +3.8% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #PRPO

[Precipio](https://eninvs.com/all.php?name=PRPO) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194071)
(2025-08-13, After Market Close):

- Revenue +40% YoY (vs +20.0% in previous quarter and historical rate +59.2%)
- EV/Sales multiple is 20.5x

At the opening of the session the share price went up +0.8% vs S&P500 -0.2%

------------------------------------------------

2025-11-15

#reports #NUWE

[Nuwellis](https://eninvs.com/all.php?name=NUWE) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194064)
(2025-08-14):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +1.4%)
- EBITDA margin -150.0% decreased compared to -50.0% same period last year
- Net Debt decreased by $13 mln over the past reporting period (110.1% of market cap)
- FCF (LTM) -$0 bln (negative), 110.1% of market cap
- EV/Sales multiple is 2.2x

------------------------------------------------

2025-11-15

#reports #MYSZ

[My Size](https://eninvs.com/all.php?name=MYSZ) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194062)
(2025-08-14):

- Revenue +50% YoY (vs 0.0% in previous quarter and historical rate +59.7%)
- EBITDA margin -33.3% increased compared to -50.0% same period last year
- EV/Sales multiple is -0.1x

------------------------------------------------

2025-11-15

#reports #LPSN

[LivePerson](https://eninvs.com/all.php?name=LPSN) (Software provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194054)
(2025-11-05, After Market Close):

- Revenue -18.9% YoY (vs -25.0% in previous quarter and historical rate -17.4%)
- EBITDA margin -15.0% decreased compared to -9.5% same period last year
- Net Debt decreased by $80 mln over the past reporting period (253.9% of market cap)
- FCF (LTM) -$0 bln (negative), 152.3% of market cap
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +2.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #KPTI

[Karyopharm Therapeutics](https://eninvs.com/all.php?name=KPTI) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194051)
(2025-08-11, Before Market Open):

- Revenue +12.8% YoY (vs -11.6% in previous quarter and historical rate -8.9%)
- EBITDA margin -31.8% increased compared to -66.7% same period last year
- Net Debt increased by $12 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 11.7% of market cap
- EV/Sales multiple is 6x

At the opening of the session the share price went up +1.5% vs S&P500 0.0%

------------------------------------------------

2025-11-15

#reports #IRWD

[Ironwood Pharmaceuticals](https://eninvs.com/all.php?name=IRWD) (Drug Manufacturers — Specialty and Generic) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194045)
(2025-11-06, Before Market Open):

- Revenue +32.6% YoY (vs -9.6% in previous quarter and historical rate -6.8%)
- EBITDA +181.5% YoY (vs +80.0% in previous quarter and historical rate +1.2%)
- EBITDA margin 62.3% increased compared to 29.3% same period last year
- Net Debt decreased by $247 mln over the past reporting period (51.1% of market cap)
- FCF (LTM) -$0.2 bln (negative), 36.8% of market cap
- EV/EBITDA multiple is 5x compared to historical level (75th percentile) of 7.1x
- EV/Sales multiple is 2.8x

At the opening of the session the share price went down -0.5% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #IRIX

[IRIDEX Corporation](https://eninvs.com/all.php?name=IRIX) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194044)
(2025-11-11, After Market Close):

- Revenue 0% YoY (vs +7.7% in previous quarter and historical rate -1.9%)
- EBITDA margin -8.3% increased compared to -16.7% same period last year
- Net Debt increased by $1 mln over the past reporting period (6.1% of market cap)
- FCF (LTM) -$0 bln (negative), 30.4% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -12.6% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #INTZ

[Intrusion](https://eninvs.com/all.php?name=INTZ) (Software — Infrastructure) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194039)
(2025-08-12, After Market Close):

- Revenue 0% YoY (vs +100.0% in previous quarter and historical rate +16.7%)
- EBITDA margin -100.0% has not changed compared to -100.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (133.4% of market cap)
- FCF (LTM) +$0 bln (positive), 133.4% of market cap
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +2.6% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #HZO

[MarineMax](https://eninvs.com/all.php?name=HZO) (Specialty Retail) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=HZO&q=2025 q3&id=902155)
(2025-11-13, Before Market Open):

- Revenue -2% YoY (vs -13.3% in previous quarter and historical rate +0.3%)
- EBITDA -49.1% YoY (vs -139.2% in previous quarter and historical rate -10.9%)
- EBITDA margin 4.9% decreased compared to 9.4% same period last year
- Net Debt decreased by $47 mln over the past reporting period (9.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 22.2% of market cap
- EV/EBITDA multiple is 19.1x compared to historical level (75th percentile) of 10.2x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -1.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #HYFM

[Hydrofarm Holdings Group, Inc.](https://eninvs.com/all.php?name=HYFM) (Farm and Heavy Construction Machinery) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194034)
(2025-08-12):

- Revenue -34.1% YoY (vs -29.1% in previous quarter and historical rate -27.3%)
- EBITDA -200% YoY (vs -1200.0% in previous quarter and historical rate +56.6%)
- EBITDA margin -6.9% decreased compared to 4.5% same period last year
- Net Debt decreased by $2 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0 bln (negative), 6.1% of market cap
- EV/EBITDA multiple is 58.3x compared to historical level (75th percentile) of 160.5x
- EV/Sales multiple is 1.6x

------------------------------------------------

2025-11-15

#reports #FWRD

[Forward Air](https://eninvs.com/all.php?name=FWRD) (Transportation services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194031)
(2025-11-05, After Market Close):

- Revenue -3.7% YoY (vs -3.9% in previous quarter and historical rate +13.7%)
- EBITDA +8.2% YoY (vs +5500.0% in previous quarter and historical rate +10.9%)
- EBITDA margin 8.4% increased compared to 7.5% same period last year
- Net Debt decreased by $60 mln over the past reporting period (10.5% of market cap)
- FCF (LTM) +$1.7 bln (positive), 302.5% of market cap
- EV/EBITDA multiple is 10x compared to historical level (75th percentile) of 15.2x
- EV/Sales multiple is 1.1x

At the opening of the session the share price went up +24.0% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #FTHM

[Fathom](https://eninvs.com/all.php?name=FTHM) (Real Estate Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194030)
(2025-11-11, After Market Close):

- Revenue +36.9% YoY (vs +536.8% in previous quarter and historical rate +9.8%)
- EBITDA margin -0.9% increased compared to -6.0% same period last year
- Net Debt decreased by $9 mln over the past reporting period (32.1% of market cap)
- FCF (LTM) -$0 bln (negative), 32.1% of market cap
- EV/Sales multiple is 0.1x

At the opening of the session the share price went down -12.1% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #FTCI

[FTC Solar, Inc.](https://eninvs.com/all.php?name=FTCI) (Solar) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194029)
(2025-08-05, Before Market Open):

- Revenue +160% YoY (vs +81.8% in previous quarter and historical rate +3.3%)
- EBITDA margin -26.9% increased compared to -150.0% same period last year
- Net Debt increased by $33 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0 bln (negative), 1.1% of market cap
- EV/Sales multiple is 17.5x

At the opening of the session the share price went down -15.3% vs S&P500 +0.1%

------------------------------------------------

2025-11-15

#reports #FF

[FutureFuel](https://eninvs.com/all.php?name=FF) (Chemicals) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194025)
(2025-11-10, After Market Close):

- Revenue -54.9% YoY (vs -50.0% in previous quarter and historical rate -22.0%)
- EBITDA margin -34.8% decreased compared to -2.0% same period last year
- Net Debt increased by $8 mln over the past reporting period (5.4% of market cap)
- FCF (LTM) -$0 bln (negative), 24.5% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +0.1% vs S&P500 -0.3%

------------------------------------------------

2025-11-15

#reports #FBIOP

[Fortress Biotech](https://eninvs.com/all.php?name=FBIOP) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194024)
(2025-08-14):

- Revenue +20% YoY (vs +6.7% in previous quarter and historical rate +2.9%)
- EBITDA +115.4% YoY (vs -3700.0% in previous quarter and historical rate +39.8%)
- EBITDA margin 155.6% increased compared to 86.7% same period last year
- Net Debt increased by $3 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0 bln (negative), 5.3% of market cap
- EV/Sales multiple is 2.9x

------------------------------------------------

2025-11-15

#reports #DXYN

[The Dixie Group](https://eninvs.com/all.php?name=DXYN) (Textile Manufacturing) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194019)
(2025-11-07, Before Market Open):

- Revenue -4.6% YoY (vs -2.8% in previous quarter and historical rate -7.0%)
- EBITDA margin -3.2% decreased compared to -3.1% same period last year
- Net Debt decreased by $2 mln over the past reporting period (24.2% of market cap)
- FCF (LTM) +$0 bln (positive), 72.6% of market cap
- EV/EBITDA multiple is 112.3x compared to historical level (75th percentile) of 17.4x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +1.2% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #DRIO

[DarioHealth](https://eninvs.com/all.php?name=DRIO) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194017)
(2025-11-13, Before Market Open):

- Revenue -28.6% YoY (vs -16.7% in previous quarter and historical rate +19.5%)
- EBITDA -16.7% YoY (vs -47.1% in previous quarter and historical rate +47.9%)
- EBITDA margin 200.0% increased compared to 171.4% same period last year
- Net Debt decreased by $35 mln over the past reporting period (6.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 12.4% of market cap
- EV/EBITDA multiple is 12.2x compared to historical level (75th percentile) of 21.9x
- EV/Sales multiple is 20x

At the opening of the session the share price went down -4.5% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #DAIO

[Data I/O Corporation](https://eninvs.com/all.php?name=DAIO) (Electronic Components) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194013)
(2025-10-30, After Market Close):

- Revenue 0% YoY (vs +20.0% in previous quarter and historical rate +1.4%)
- EBITDA margin -20.0% decreased compared to 0.0% same period last year
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -2.2% vs S&P500 +0.8%

------------------------------------------------

2025-11-15

#reports #BKTI

[BK Technologies Corporation](https://eninvs.com/all.php?name=BKTI) (Communication Equipment) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194001)
(2025-11-06, Before Market Open):

- Revenue +20% YoY (vs +5.0% in previous quarter and historical rate +31.1%)
- EBITDA +66.7% YoY (vs +100.0% in previous quarter)
- EBITDA margin 20.8% increased compared to 15.0% same period last year
- Net Debt decreased by $10 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 72.7x compared to historical level (75th percentile) of 93.6x
- EV/Sales multiple is 13.3x

At the opening of the session the share price went down -1.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #BFRI

[Biofrontera Inc.](https://eninvs.com/all.php?name=BFRI) (Drug Manufacturers — Specialty and Generic) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193998)
(2025-08-13, Before Market Open):

- Revenue -22.2% YoY (vs +12.5% in previous quarter and historical rate +29.1%)
- EBITDA margin -85.7% decreased compared to -55.6% same period last year
- Net Debt increased by $4 mln over the past reporting period (18.3% of market cap)
- FCF (LTM) +$0 bln (positive), 27.5% of market cap
- EV/Sales multiple is 0.4x

At the opening of the session the share price went down -2.2% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #BBGI

[Beasley Broadcast Group](https://eninvs.com/all.php?name=BBGI) (Broadcasting) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193994)
(2025-11-10, Before Market Open):

- Revenue -12.4% YoY (vs -12.3% in previous quarter and historical rate -4.8%)
- EBITDA -57.8% YoY (vs -40.6% in previous quarter and historical rate +42.1%)
- EBITDA margin 1.9% decreased compared to 4.0% same period last year
- Net Debt decreased by $5.5 bln since the start of the year (4514.2% of market cap)
- FCF (LTM) +$5.3 bln (positive), 4343.7% of market cap
- EV/EBITDA multiple is 18x compared to historical level (75th percentile) of 16.8x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went down -15.1% vs S&P500 +1.1%

------------------------------------------------

2025-11-15

#reports #AWH

[Aspira Women's Health](https://eninvs.com/all.php?name=AWH) (Treatments for gynecological problems developer ) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193992)
(2023-08-14, Before Market Open):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate 0.0%)
- EBITDA margin -100.0% increased compared to -200.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (264.1% of market cap)
- EV/Sales multiple is 0.7x

At the opening of the session the share price went up +0.6%

------------------------------------------------

2025-11-15

#reports #ATNI

[ATN International](https://eninvs.com/all.php?name=ATNI) (Telecommunications company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193985)
(2025-11-05, After Market Close):

- Revenue +2.8% YoY (vs -1.1% in previous quarter and historical rate +27.8%)
- EBITDA margin 24.0% increased compared to 0.6% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0 bln (negative), 7.6% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 11x
- EV/Sales multiple is 0.9x

At the opening of the session the share price went up +6.3% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #AGEN

[Agenus](https://eninvs.com/all.php?name=AGEN) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193979)
(2025-11-10, Before Market Open):

- Revenue +20% YoY (vs +8.3% in previous quarter and historical rate +18.3%)
- EBITDA margin -6.7% increased compared to -112.0% same period last year
- Net Debt decreased by $69 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 3.0% of market cap
- EV/Sales multiple is 16.3x

------------------------------------------------

2025-11-15

#reports #ADES

[Advanced Emissions Solutions](https://eninvs.com/all.php?name=ADES) (Pollution and Treatment Controls) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193977)
(2023-11-08, After Market Close):

- Revenue 0% YoY (vs +16.0% in previous quarter and historical rate +21.0%)
- EBITDA -14.3% YoY (vs +50.0% in previous quarter)
- EBITDA margin 17.1% decreased compared to 20.0% same period last year
- Net Debt decreased by $3 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 36.6% of market cap
- EV/EBITDA multiple is 22.6x compared to historical level (75th percentile) of 29.3x
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +0.5%

------------------------------------------------

2025-11-15

#reports #BEEM
@ renewable-energy

[Beam Global](https://eninvs.com/all.php?name=BEEM) (Solar) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193997)
(2025-11-13, After Market Close):

- Revenue -45.5% YoY (vs -53.3% in previous quarter and historical rate +49.5%)
- EBITDA -300% YoY (vs -500.0% in previous quarter)
- EBITDA margin -66.7% decreased compared to 18.2% same period last year
- EV/Sales multiple is 1x

At the opening of the session the share price went down -2.8% vs S&P500 -1.1%

------------------------------------------------

2025-11-15

#reports #SE
@ gaming

[Sea](https://eninvs.com/all.php?name=SE) (Electronic Gaming and Multimedia) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=SE&q=2025 q3&id=901650)
(2025-11-11, Before Market Open):

- Revenue +38.3% YoY (vs +38.1% in previous quarter and historical rate +20.5%)
- EBITDA +121.2% YoY (vs +279.3% in previous quarter and historical rate +109.2%)
- EBITDA margin 8.4% increased compared to 5.2% same period last year
- Net Debt decreased by $439 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$1.7 bln (positive), 2.2% of market cap
- EV/EBITDA multiple is 39.6x compared to historical level (75th percentile) of 133.4x
- EV/Sales multiple is 3.5x

At the opening of the session the share price went up +2.4% vs S&P500 -0.3%

------------------------------------------------

2025-11-13

#reports #TTEK

[Tetra Tech](https://eninvs.com/all.php?name=TTEK) (Consulting company) reported for 2025 q3
(2025-11-12, After Market Close):

- Revenue -3.2% YoY (vs +1.9% in previous quarter and historical rate +19.0%)
- EBITDA +22.5% YoY (vs +20.9% in previous quarter and historical rate +7.0%)
- EBITDA margin 14.7% increased compared to 11.6% same period last year
- Net Debt decreased by $9 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 1.2% of market cap
- EV/EBITDA multiple is 5.5x compared to historical level (75th percentile) of 23.5x
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-11-13

#reports #SSTI

[ShotSpotter](https://eninvs.com/all.php?name=SSTI) (Software — Application) reported for 2025 q3
(2025-11-12, After Market Close):

- Revenue -3.8% YoY (vs -3.7% in previous quarter and historical rate +17.6%)
- EBITDA margin -8.0% decreased compared to -3.8% same period last year
- Net Debt decreased by $3 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) -$0 bln (negative), 6.8% of market cap
- EV/Sales multiple is 0.9x

------------------------------------------------

2025-11-13

#reports #RSKD

[Riskified Ltd.](https://eninvs.com/all.php?name=RSKD) (Software — Application) reported for 2025 q3
(2025-11-12, Before Market Open):

- Revenue +3.8% YoY (vs +2.5% in previous quarter and historical rate +10.3%)
- EBITDA margin -6.1% increased compared to -12.7% same period last year
- Net Debt increased by $14 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 7.8% of market cap
- EV/Sales multiple is 1.5x

At the opening of the session the share price went up +1.8% vs S&P500 +0.3%

------------------------------------------------

2025-11-13

#reports #IDN

[Intellicheck](https://eninvs.com/all.php?name=IDN) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193955)
(2025-11-05, After Market Close):

- Revenue +20% YoY (vs 0.0% in previous quarter and historical rate +29.4%)
- Net Debt increased by $1 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) +$0 bln (positive), 3.5% of market cap
- EV/EBITDA multiple is 76.5x compared to historical level (75th percentile) of 46x
- EV/Sales multiple is 2.5x

At the opening of the session the share price went up +0.2% vs S&P500 -0.4%

------------------------------------------------

2025-11-13

#reports #EWCZ

[European Wax Center, Inc.](https://eninvs.com/all.php?name=EWCZ) (Household and Personal Products) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193953)
(2025-11-12, Before Market Open):

- Revenue -1.8% YoY (vs -6.7% in previous quarter and historical rate +17.6%)
- EBITDA +26.7% YoY (vs 0.0% in previous quarter and historical rate +25.2%)
- EBITDA margin 35.2% increased compared to 27.3% same period last year
- Net Debt decreased by $12 mln over the past reporting period (4.4% of market cap)
- FCF (LTM) +$0 bln (positive), 5.8% of market cap
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 21x
- EV/Sales multiple is 2.9x

At the opening of the session the share price went up +9.6% vs S&P500 +0.3%

------------------------------------------------

2025-11-13

#reports #EGAN

[eGain](https://eninvs.com/all.php?name=EGAN) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193950)
(2025-09-04, After Market Close):

- Revenue +9.1% YoY (vs -67.1% in previous quarter and historical rate +8.1%)
- EBITDA margin 12.5% increased compared to 4.5% same period last year
- Net Debt decreased by $9 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) +$0 bln (positive), 1.2% of market cap
- EV/EBITDA multiple is 28.7x compared to historical level (75th percentile) of 32.4x
- EV/Sales multiple is 3.8x

At the opening of the session the share price went up +2.1% vs S&P500 +0.4%

------------------------------------------------

2025-11-13

#reports #DGII

[Digi International](https://eninvs.com/all.php?name=DGII) (Communication Equipment) reported for 2025 q3
(2025-11-12, After Market Close):

- Revenue +8.6% YoY (vs +2.9% in previous quarter and historical rate +4.1%)
- EBITDA -7.7% YoY (vs +8.7% in previous quarter)
- EBITDA margin 10.5% decreased compared to 12.4% same period last year
- Net Debt increased by $117 mln over the past reporting period (8.8% of market cap)
- FCF (LTM) +$0 bln (positive), 1.8% of market cap
- EV/EBITDA multiple is 18.6x compared to historical level (75th percentile) of 20.9x
- EV/Sales multiple is 3.4x

------------------------------------------------

2025-11-13

#reports #DERM

[Journey Medical Corporation](https://eninvs.com/all.php?name=DERM) (Drug Manufacturers — Specialty and Generic) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193948)
(2025-11-05, After Market Close):

- Revenue +20% YoY (vs 0.0% in previous quarter and historical rate -4.3%)
- EBITDA margin -5.6% increased compared to -13.3% same period last year
- Net Debt decreased by $4 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) -$0 bln (negative), 3.8% of market cap
- EV/Sales multiple is 3.1x

At the opening of the session the share price went up +1.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-13

#reports #CCRN

[Cross Country Healthcare](https://eninvs.com/all.php?name=CCRN) (Medical Care Facilities) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193944)
(2025-11-03, After Market Close):

- Revenue -20.6% YoY (vs -19.4% in previous quarter and historical rate -25.7%)
- EBITDA -128.6% YoY (vs -300.0% in previous quarter and historical rate -67.7%)
- EBITDA margin -0.8% decreased compared to 2.2% same period last year
- Net Debt decreased by $19 mln over the past reporting period (4.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.2% of market cap
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -0.7% vs S&P500 -0.9%

------------------------------------------------

2025-11-13

#reports #AP

[Ampco-Pittsburgh Corporation](https://eninvs.com/all.php?name=AP) (Metal Fabrication) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193940)
(2025-11-12, After Market Close):

- Revenue +12.5% YoY (vs +1.8% in previous quarter and historical rate +4.0%)
- EBITDA -89.7% YoY (vs -80.0% in previous quarter and historical rate +39.6%)
- EBITDA margin 7.4% decreased compared to 81.3% same period last year
- Net Debt decreased by $4 mln over the past reporting period (10.4% of market cap)
- FCF (LTM) -$0 bln (negative), 13.0% of market cap
- EV/EBITDA multiple is 1.7x compared to historical level (75th percentile) of 8.3x
- EV/Sales multiple is 0.4x

------------------------------------------------

2025-11-13

#reports #HUYA
@ china , @ gaming

[HUYA](https://eninvs.com/all.php?name=HUYA) (Entertainment) reported for 2025 q3
(2025-11-12, Before Market Open):

- Revenue +8.2% YoY (vs +3.3% in previous quarter and historical rate -13.7%)
- EBITDA +4.9% YoY (vs -400.0% in previous quarter and historical rate +18.7%)
- EBITDA margin 27.0% decreased compared to 27.9% same period last year
- Net Debt decreased by $41 mln over the past reporting period (6.4% of market cap)
- FCF (LTM) -$0.4 bln (negative), 69.5% of market cap
- EV/EBITDA multiple is 1.9x compared to historical level (75th percentile) of 4.3x
- EV/Sales multiple is 0.1x

At the opening of the session the share price went up +2.9% vs S&P500 +0.3%

------------------------------------------------

2025-11-13

#reports #GWRS

[Global Water Resources](https://eninvs.com/all.php?name=GWRS) (Utilities — Regulated Water) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193930)
(2025-11-13, Before Market Open):

- Revenue +14.3% YoY (vs 0.0% in previous quarter and historical rate +16.5%)
- EBITDA +42.9% YoY (vs 0.0% in previous quarter and historical rate +7.5%)
- EBITDA margin 62.5% increased compared to 50.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0 bln (positive), 2.2% of market cap
- EV/EBITDA multiple is 16.5x compared to historical level (75th percentile) of 19.3x
- EV/Sales multiple is 5.9x

------------------------------------------------

2025-11-11

#reports #TSQ

[Townsquare Media](https://eninvs.com/all.php?name=TSQ) (Advertising Agencies) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193926)
(2025-11-10, Before Market Open):

- Revenue -7% YoY (vs -2.5% in previous quarter and historical rate -1.0%)
- EBITDA -25% YoY (vs +2500.0% in previous quarter and historical rate +14.8%)
- EBITDA margin 14.0% decreased compared to 17.4% same period last year
- Net Debt decreased by $1 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0 bln (positive), 22.7% of market cap
- EV/EBITDA multiple is 6.9x compared to historical level (75th percentile) of 17.5x
- EV/Sales multiple is 1.3x

At the opening of the session the share price went down -2.6% vs S&P500 +1.1%

------------------------------------------------

2025-11-11

#reports #TBPH

[Theravance Biopharma](https://eninvs.com/all.php?name=TBPH) (Biotechnology) reported for 2025 q3
(2025-11-10, After Market Close):

- Revenue +17.6% YoY (vs +85.7% in previous quarter and historical rate +34.8%)
- EBITDA margin -30.0% increased compared to -58.8% same period last year
- Net Debt increased by $7 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.3 bln (positive), 23.2% of market cap
- EV/EBITDA multiple is 135.6x compared to historical level (75th percentile) of 362x
- EV/Sales multiple is 10.2x

------------------------------------------------

2025-11-11

#reports #SIBN

[SI-BONE](https://eninvs.com/all.php?name=SIBN) (Medical device manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193924)
(2025-11-10, After Market Close):

- Revenue +22.5% YoY (vs +22.5% in previous quarter and historical rate +25.5%)
- EBITDA margin -10.2% increased compared to -17.5% same period last year
- EV/Sales multiple is 2.2x

At the opening of the session the share price went up +0.5%

------------------------------------------------

2025-11-11

#reports #RRGB

[Red Robin Gourmet Burgers](https://eninvs.com/all.php?name=RRGB) (Restaurant chain owner) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193921)
(2025-11-10, After Market Close):

- Revenue -3.6% YoY (vs -5.3% in previous quarter and historical rate -0.6%)
- EBITDA margin -4.5% increased compared to -4.7% same period last year
- Net Debt increased by $6 mln over the past reporting period (7.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 77.7% of market cap
- EV/EBITDA multiple is 49.1x compared to historical level (75th percentile) of 55.8x
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-11-11

#reports #RAIL

[FreightCar America](https://eninvs.com/all.php?name=RAIL) (Railroads) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193916)
(2025-11-10, Before Market Open):

- Revenue +42.5% YoY (vs -19.0% in previous quarter and historical rate +27.0%)
- EBITDA +60% YoY (vs -40.0% in previous quarter and historical rate +86.4%)
- EBITDA margin 9.9% increased compared to 8.8% same period last year
- Net Debt increased by $16 mln over the past reporting period (5.3% of market cap)
- FCF (LTM) +$0 bln (positive), 9.3% of market cap
- EV/EBITDA multiple is 12.5x compared to historical level (75th percentile) of 18.3x
- EV/Sales multiple is 1x

At the opening of the session the share price went up +5.0% vs S&P500 +1.1%

------------------------------------------------

2025-11-11

#reports #QRHC

[Quest Resource Corporation](https://eninvs.com/all.php?name=QRHC) (Waste Management) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193914)
(2025-11-10, After Market Close):

- Revenue -13.7% YoY (vs -17.8% in previous quarter and historical rate +3.2%)
- EBITDA margin 4.8% increased compared to 1.4% same period last year
- Net Debt decreased by $5 mln over the past reporting period (17.2% of market cap)
- FCF (LTM) +$0 bln (positive), 3.4% of market cap
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +1.1%

------------------------------------------------

2025-11-11

#reports #PUBM

[PubMatic, Inc.](https://eninvs.com/all.php?name=PUBM) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193913)
(2025-11-10, After Market Close):

- Revenue -5.6% YoY (vs +6.0% in previous quarter and historical rate +4.2%)
- EBITDA -17.6% YoY (vs -14.3% in previous quarter and historical rate +3.6%)
- EBITDA margin 20.6% decreased compared to 23.6% same period last year
- Net Debt decreased by $20 mln over the past reporting period (5.5% of market cap)
- FCF (LTM) -$0 bln (negative), 9.1% of market cap
- EV/EBITDA multiple is 4x compared to historical level (75th percentile) of 11x
- EV/Sales multiple is 0.9x

------------------------------------------------

2025-11-11

#reports #ONTF

[ON24, Inc.](https://eninvs.com/all.php?name=ONTF) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193909)
(2025-11-10, After Market Close):

- Revenue -2.8% YoY (vs -5.4% in previous quarter and historical rate -10.1%)
- EBITDA margin -11.4% increased compared to -25.0% same period last year
- Net Debt increased by $4 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 4.7% of market cap
- EV/Sales multiple is 0.4x

------------------------------------------------

2025-11-11

#reports #NGS

[Natural Gas Services Group](https://eninvs.com/all.php?name=NGS) (Oil and Gas Equipment and Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193908)
(2025-11-10, After Market Close):

- Revenue +4.9% YoY (vs +7.9% in previous quarter and historical rate +37.6%)
- EBITDA -20% YoY (vs +18.8% in previous quarter and historical rate +62.1%)
- EBITDA margin 46.5% decreased compared to 61.0% same period last year
- Net Debt increased by $26 mln over the past reporting period (6.9% of market cap)
- FCF (LTM) -$0 bln (negative), 11.6% of market cap
- EV/EBITDA multiple is 7.2x compared to historical level (75th percentile) of 8.9x
- EV/Sales multiple is 2.9x

At the opening of the session the share price went up +0.1%

------------------------------------------------

2025-11-11

#reports #MNDY

[monday.com Ltd.](https://eninvs.com/all.php?name=MNDY) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=MNDY&q=2025 q3&id=901486)
(2025-11-10, Before Market Open):

- Revenue +26.3% YoY (vs +26.7% in previous quarter and historical rate +36.4%)
- EBITDA margin 0.3% increased compared to -9.6% same period last year
- Net Debt decreased by $96 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) +$0.3 bln (positive), 4.4% of market cap
- EV/EBITDA multiple is 352.9x compared to historical level (75th percentile) of 2935.3x
- EV/Sales multiple is 4.8x

At the opening of the session the share price went down -20.3% vs S&P500 +1.1%

------------------------------------------------

2025-11-11

#reports #MASS

[908 Devices Inc.](https://eninvs.com/all.php?name=MASS) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193905)
(2025-11-10, Before Market Open):

- Revenue -17.6% YoY (vs -7.1% in previous quarter and historical rate +17.2%)
- EBITDA margin -107.1% increased compared to -176.5% same period last year
- Net Debt increased by $6 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0 bln (positive), 20.3% of market cap
- EV/Sales multiple is 2x

At the opening of the session the share price went down -18.7% vs S&P500 +1.1%

------------------------------------------------

2025-11-11

#reports #KLTR

[Kaltura, Inc.](https://eninvs.com/all.php?name=KLTR) (Software — Infrastructure) reported for 2025 q3
(2025-11-10, After Market Close):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +2.5%)
- EBITDA -44.4% YoY (vs -46.2% in previous quarter and historical rate +26.3%)
- EBITDA margin 11.4% decreased compared to 20.5% same period last year
- Net Debt decreased by $2 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0 bln (negative), 1.6% of market cap
- EV/EBITDA multiple is 6.3x compared to historical level (75th percentile) of 6.5x
- EV/Sales multiple is 0.9x

------------------------------------------------

2025-11-11

#reports #INVE

[Identiv](https://eninvs.com/all.php?name=INVE) (Computer Hardware) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193900)
(2025-11-10, After Market Close):

- Revenue -28.6% YoY (vs -28.6% in previous quarter and historical rate -30.5%)
- EBITDA margin -100.0% increased compared to -128.6% same period last year
- Net Debt increased by $3 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) -$0 bln (negative), 16.9% of market cap
- EV/EBITDA multiple is 2x compared to historical level (75th percentile) of 68.5x
- EV/Sales multiple is -1.7x

At the opening of the session the share price went up +0.9%

------------------------------------------------

2025-11-11

#reports #HCAT

[Health Catalyst](https://eninvs.com/all.php?name=HCAT) (Software provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193895)
(2025-11-10, After Market Close):

- Revenue 0% YoY (vs +6.6% in previous quarter and historical rate +5.2%)
- EBITDA margin 10.5% increased compared to -5.3% same period last year
- Net Debt increased by $6 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 46.9% of market cap
- EV/Sales multiple is 0.9x

------------------------------------------------

2025-11-11

#reports #EVI

[EVI Industries](https://eninvs.com/all.php?name=EVI) (Industrial Distribution) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193877)
(2025-11-11, Before Market Open):

- Revenue +14.9% YoY (vs +22.2% in previous quarter and historical rate +13.2%)
- EBITDA -14.3% YoY (vs +20.0% in previous quarter and historical rate +25.0%)
- EBITDA margin 5.6% decreased compared to 7.4% same period last year
- Net Debt increased by $4 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$0 bln (negative), 9.9% of market cap
- EV/EBITDA multiple is 20x compared to historical level (75th percentile) of 16.1x
- EV/Sales multiple is 1x

At the opening of the session the share price went down -1.6%

------------------------------------------------

2025-11-11

#reports #CVGI

[Commercial Vehicle Group](https://eninvs.com/all.php?name=CVGI) (Auto Parts) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193876)
(2025-11-11, After Market Close):

- Revenue -11.6% YoY (vs -25.2% in previous quarter and historical rate -11.4%)
- EBITDA 0% YoY (vs -20.0% in previous quarter and historical rate +4.3%)
- EBITDA margin 7.2% increased compared to 6.4% same period last year
- Net Debt increased by $4 mln over the past reporting period (7.8% of market cap)
- FCF (LTM) +$0 bln (positive), 1.9% of market cap
- EV/EBITDA multiple is 7.3x compared to historical level (75th percentile) of 8.8x
- EV/Sales multiple is 0.2x

------------------------------------------------

2025-11-11

#reports #CHGG

[Chegg](https://eninvs.com/all.php?name=CHGG) (Learning platform for schoolchildren and students) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193889)
(2025-11-10, After Market Close):

- Revenue -43.1% YoY (vs -35.6% in previous quarter and historical rate -15.9%)
- EBITDA margin -2.6% increased compared to -148.2% same period last year
- Net Debt decreased by $13 mln over the past reporting period (14.1% of market cap)
- FCF (LTM) +$0.3 bln (positive), 292.6% of market cap
- EV/Sales multiple is 0.2x

At the opening of the session the share price went neutrally

------------------------------------------------

2025-11-11

#reports #CEVA

[CEVA](https://eninvs.com/all.php?name=CEVA) (Wireless and intelligent sensor platforms licensor ) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193888)
(2025-11-10, Before Market Open):

- Revenue +3.7% YoY (vs -7.1% in previous quarter and historical rate -6.1%)
- EBITDA margin -3.6% increased compared to -7.4% same period last year
- Net Debt increased by $5 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/Sales multiple is 4.4x

At the opening of the session the share price went up +5.1% vs S&P500 +1.1%

------------------------------------------------

2025-11-11

#reports #CBAT

[CBAK Energy Technology](https://eninvs.com/all.php?name=CBAT) (Electrical Equipment and Parts) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193887)
(2025-11-10, Before Market Open):

- Revenue 0% YoY (vs +14.3% in previous quarter and historical rate +2.8%)
- EBITDA margin -4.4% decreased compared to 2.2% same period last year
- Net Debt decreased by $6 mln over the past reporting period (7.3% of market cap)
- FCF (LTM) -$0 bln (negative), 1.2% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +4.7% vs S&P500 +1.1%

------------------------------------------------

2025-11-11

#reports #ASRT

[Assertio](https://eninvs.com/all.php?name=ASRT) (Drug Manufacturers — Specialty and Generic) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193884)
(2025-11-10, After Market Close):

- Revenue -31% YoY (vs -6.5% in previous quarter and historical rate +2.3%)
- EBITDA +525% YoY (vs -66.7% in previous quarter and historical rate -29.9%)
- EBITDA margin 125.0% increased compared to 13.8% same period last year
- Net Debt increased by $5 mln over the past reporting period (13.0% of market cap)
- FCF (LTM) +$0 bln (positive), 23.5% of market cap
- EV/EBITDA multiple is 3.1x compared to historical level (75th percentile) of 3.2x
- EV/Sales multiple is -0.1x

At the opening of the session the share price went down -0.1%

------------------------------------------------

2025-11-11

#reports #AKBA

[Akebia Therapeutics](https://eninvs.com/all.php?name=AKBA) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193881)
(2025-11-10, Before Market Open):

- Revenue +59.5% YoY (vs +40.9% in previous quarter and historical rate +3.1%)
- EBITDA margin 6.8% increased compared to -35.1% same period last year
- Net Debt decreased by $30 mln over the past reporting period (8.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 28.2% of market cap
- EV/EBITDA multiple is 3.8x compared to historical level (75th percentile) of 57.7x
- EV/Sales multiple is 0.9x

At the opening of the session the share price went down -15.2% vs S&P500 +1.1%

------------------------------------------------

2025-11-11

#reports #PLUG
@ renewable-energy

[Plug Power](https://eninvs.com/all.php?name=PLUG) (Handling equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193879)
(2025-11-11, After Market Close):

- Revenue +1.7% YoY (vs +21.7% in previous quarter and historical rate +7.0%)
- EBITDA margin -194.9% decreased compared to -121.8% same period last year
- Net Debt decreased by $5 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/Sales multiple is 5x

------------------------------------------------

2025-11-08

#reports #HUN

[Huntsman Corporation](https://eninvs.com/all.php?name=HUN) (Chemical products manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193758)
(2025-11-06, After Market Close):

- Revenue -5.2% YoY (vs -7.4% in previous quarter and historical rate -12.1%)
- EBITDA -94.6% YoY (vs -210.1% in previous quarter and historical rate -23.8%)
- EBITDA margin 0.4% decreased compared to 7.3% same period last year
- Net Debt decreased by $58 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) -$0.5 bln (negative), 27.6% of market cap
- EV/EBITDA multiple is 347x compared to historical level (75th percentile) of 21.1x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +4.3% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #GNRC

[Generac](https://eninvs.com/all.php?name=GNRC) (Power generation equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193749)
(2025-10-29, Before Market Open):

- Revenue -5.1% YoY (vs +6.3% in previous quarter and historical rate -1.1%)
- EBITDA -32.4% YoY (vs +10.7% in previous quarter and historical rate +5.7%)
- EBITDA margin 11.4% decreased compared to 16.0% same period last year
- Net Debt decreased by $68 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 2.1% of market cap
- EV/EBITDA multiple is 18x compared to historical level (75th percentile) of 21.7x
- EV/Sales multiple is 2.4x

At the opening of the session the share price went down -10.9% vs S&P500 +0.3%

------------------------------------------------

2025-11-08

#reports #GLP

[Global Partners LP](https://eninvs.com/all.php?name=GLP) (Oil and Gas Midstream) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193747)
(2025-11-07, Before Market Open):

- Revenue +6.2% YoY (vs +4.9% in previous quarter and historical rate -2.8%)
- EBITDA -47.8% YoY (vs +84.6% in previous quarter and historical rate +13.4%)
- EBITDA margin 2.1% decreased compared to 4.2% same period last year
- Net Debt increased by $49 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 0.9x compared to historical level (75th percentile) of 9.6x
- EV/Sales multiple is 0.2x

At the opening of the session the share price went down -6.9% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #AXL

[American Axle & Manufacturing](https://eninvs.com/all.php?name=AXL) (Auto Parts) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193695)
(2025-11-07, Before Market Open):

- Revenue 0% YoY (vs -5.9% in previous quarter and historical rate +1.4%)
- EBITDA +3.8% YoY (vs -18.0% in previous quarter and historical rate +14.1%)
- EBITDA margin 11.0% increased compared to 10.6% same period last year
- Net Debt decreased by $136 mln over the past reporting period (18.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 14.7% of market cap
- EV/EBITDA multiple is 4.3x compared to historical level (75th percentile) of 4.9x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -2.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #AHT

[Ashford Hospitality Trust](https://eninvs.com/all.php?name=AHT) (REIT — Hotel and Motel) reported for 2025 q3
(2025-02-27, After Market Close):

- Revenue -4% YoY (vs -4.4% in previous quarter and historical rate 0.0%)
- EBITDA -19% YoY (vs -50.9% in previous quarter and historical rate +10.7%)
- EBITDA margin 17.7% decreased compared to 20.9% same period last year
- Net Debt increased by $15 mln over the past reporting period (66.7% of market cap)
- FCF (LTM) -$0 bln (negative), 80.1% of market cap
- EV/Sales multiple is -0.1x

At the opening of the session the share price went down -2.4% vs S&P500 -0.3%

------------------------------------------------

2025-11-08

#reports #CPT
@ REITs

[Camden Property Trust](https://eninvs.com/all.php?name=CPT) (Real estate investment fund) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193661)
(2025-11-06, After Market Close):

- Revenue +2.3% YoY (vs +2.6% in previous quarter and historical rate +5.5%)
- EBITDA +90.3% YoY (vs +22.9% in previous quarter and historical rate -0.3%)
- EBITDA margin 69.2% increased compared to 37.2% same period last year
- Net Debt increased by $11 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.1% of market cap
- EV/EBITDA multiple is 12.5x compared to historical level (75th percentile) of 14.6x
- EV/Sales multiple is 7.1x

At the opening of the session the share price went up +0.2% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #WTTR

[Select Energy Services](https://eninvs.com/all.php?name=WTTR) (Complete water supply solution provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193491)
(2025-11-04, After Market Close):

- Revenue -13.2% YoY (vs -0.3% in previous quarter and historical rate +16.6%)
- EBITDA -32.8% YoY (vs -1.7% in previous quarter and historical rate +29.9%)
- EBITDA margin 13.4% decreased compared to 17.3% same period last year
- Net Debt increased by $59 mln over the past reporting period (6.1% of market cap)
- FCF (LTM) -$0.2 bln (negative), 20.1% of market cap
- EV/EBITDA multiple is 7x compared to historical level (75th percentile) of 5.3x
- EV/Sales multiple is 1x

At the opening of the session the share price went down -2.7% vs S&P500 -0.1%

------------------------------------------------

2025-11-08

#reports #WEYS

[Weyco Group](https://eninvs.com/all.php?name=WEYS) (Footwear and Accessories) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193488)
(2025-03-11, After Market Close):

- Revenue -1.4% YoY (vs -9.4% in previous quarter and historical rate -7.3%)
- EBITDA -27.3% YoY (vs -42.9% in previous quarter and historical rate -5.1%)
- EBITDA margin 11.0% decreased compared to 14.9% same period last year
- Net Debt increased by $4 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.6% of market cap
- EV/EBITDA multiple is 7.8x compared to historical level (75th percentile) of 6.5x
- EV/Sales multiple is 0.9x

At the opening of the session the share price went neutrally vs S&P500 +0.9%

------------------------------------------------

2025-11-08

#reports #WEN

[Wendys](https://eninvs.com/all.php?name=WEN) (Restaurants) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193487)
(2025-11-07, Before Market Open):

- Revenue -3% YoY (vs -1.8% in previous quarter and historical rate +25.9%)
- EBITDA -1% YoY (vs +8.7% in previous quarter and historical rate -7.7%)
- EBITDA margin 17.6% increased compared to 17.3% same period last year
- Net Debt increased by $6 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 3.6% of market cap
- EV/EBITDA multiple is 14.4x compared to historical level (75th percentile) of 18x
- EV/Sales multiple is 2.6x

At the opening of the session the share price went up +11.0% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #TRVG

[Trivago](https://eninvs.com/all.php?name=TRVG) (Internet Content and Information) reported for 2025 q3
(2024-02-06, Before Market Open):

- Revenue +13.7% YoY (vs +16.8% in previous quarter and historical rate +1.9%)
- EBITDA margin 7.8% increased compared to -13.0% same period last year
- Net Debt decreased by $19 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 1.9% of market cap
- EV/Sales multiple is 2.1x

At the opening of the session the share price went down -1.2%

------------------------------------------------

2025-11-08

#reports #TRUE

[TrueCar](https://eninvs.com/all.php?name=TRUE) (Internet Content and Information) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193482)
(2025-11-05, After Market Close):

- Revenue -8.5% YoY (vs +11.9% in previous quarter and historical rate +2.7%)
- EBITDA margin -11.6% decreased compared to -6.4% same period last year
- Net Debt decreased by $11 mln over the past reporting period (5.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 54.6% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +0.9% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #STAA

[STAAR Surgical Co](https://eninvs.com/all.php?name=STAA) (Implantable contact lenses manufacturer ) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193478)
(2025-10-20, Before Market Open):

- Revenue +6.7% YoY (vs -55.6% in previous quarter and historical rate -0.9%)
- EBITDA +185.7% YoY (vs -315.4% in previous quarter)
- EBITDA margin 21.1% increased compared to 7.9% same period last year
- Net Debt decreased by $10 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0 bln (positive), 1.1% of market cap
- EV/Sales multiple is 5.1x

At the opening of the session the share price went down -0.1% vs S&P500 +0.4%

Switch to company model in classical logic    *